CASE REPORT
Osteomalacia in 41-year-old female patient in the course of severe vitamin D deficiency and secondary hyperparathyroidism
More details
Hide details
Submission date: 2013-07-10
Final revision date: 2013-08-28
Acceptance date: 2013-11-18
Online publication date: 2013-12-24
Publication date: 2013-12-20
Reumatologia 2013;51(6):467-470
KEYWORDS
TOPICS
ABSTRACT
Osteomalacia is a metabolic bone disease, in which there is insufficient mineralization of the organic bone matrix in adults. The most common cause of osteomalacia is vitamin D deficiency. Reported symptoms are diffuse bone pain, fatigue and muscle weakness. Laboratory tests show lower levels of calcium and inorganic phosphate in the serum, an increase in alkaline phosphatase, urinary calcium excretion reduction, and lower level of vitamin D in serum. A case of osteomalacia in a 41-year-old woman in the course of severe vitamin D deficiency, with characteristic clinical and laboratory symptoms was presented. The severity of symptoms and ambiguous descriptions of imaging tests of skeletal system have led to the differential diagnosis taking into account neoplastic diseases. In the article it is shown, how important, in the diagnosis and cure of the patient, determining the level of vitamin D and its supplementation with calcium preparations turned out to be.
REFERENCES (14)
1.
Horst-Sikorska W. Osteomalacja. W: Reumatologia. Puszczewicz M (red.). Medical Tribune Polska, Warszawa 2011; 433-435.
2.
Tłustochowicz W. Osteoporoza i osteomalacja. W: Reumatologia kliniczna. Zimmermann-Górska I (red.). Wydawnictwo Lekarskie PZWL, Warszawa 2008; 917-918.
3.
Marcinowska-Suchowierska E, Tałałaj M. Osteomalacja. W: Choroby metaboliczne kości. Badurski J (red.). Borgis, Warszawa 2005; 144-158.
4.
Bouillon R, Carmeliet G, Daci E, et al. Vitamin D metabolism and action. Osteoporosis Int 1998; Suppl. 8: S13-S19.
5.
Brown AJ. Regulation of vitamin D action. Nephrol Dial Transplant 1999; 14: 11-16.
6.
Lorentzon M, Lorentzon R, Nordstrom P. Vitamin D receptor gene polymorphism is related to bone density, circulating osteocalcin and parathyroid hormone in healthy adolescent girls. J Bone Miner Metab 2001; 19: 302-307.
7.
Galus K, Jaworski Z. Krzywica i osteomalacja. Choroby metaboliczne kości. PZWL, Warszawa 1982.
8.
Marcinowska-Suchowierska E. Zaburzenia gospodarki Ca–P–Mg i metabolizmu witaminy D oraz zmiany kostne w przewlekłych chorobach przewodu pokarmowego i wątroby. W: Zaburzenia gospodarki wapniowo-fosforanowo-magnezowej i witaminy D. CMKP, Warszawa 1998.
9.
Tłustochowicz W, Korkosz M. Choroby metaboliczne kości. Osteomalacja. W: Choroby wewnętrzne. Szczeklik A (red.). Medycyna Praktyczna, Kraków 2006; 1748-1749.
10.
Glerup H, Mikkelsen K, Poulsen L, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 2000; 66: 419-424.
11.
Albany C, Servetnyk Z. Disabling osteomalacia and myopathy as the only presenting features of celiac disease: a case report. Cases J 2009; 2: 20.
12.
Sahebari M, Sigari SY, Heidari H, Biglarian O. Osteomalacia can still be a point of attention to celiac disease. Clin Cases Miner Bone Metab 2011; 8: 14-15.
13.
Rabelink NM, Westgeest HM, Bravenboer N, et al. Bone pain and extremely low bone mineral density due to serve vitamin D deficiency in celiac disease. Arch Osteoporos 2011; 6: 209-213.
14.
Rastoqi A, Bhadada SK, Bhansali A, et al. Celiac disease: A missed cause of metabolic bone disease. Indian J Endocrinol Metab 2012; 16: 780-785.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.